AstraZeneca to Evaluate Orexo Respiratory Programme Previously Partnered with Janssen
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 2 (Table of Contents)
Published: 8 Feb-2013
DOI: 10.3833/pdr.v2013.i2.1894 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AstraZeneca has been granted rights to evaluate Orexo’s preclinical OX-CLI programme for respiratory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS